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OBJECTIVES The purposes of this study were to test the specificity of dipyridamole myocardial perfusion
scintigraphy in patients with permanent ventricular pacing (PVP) and to evaluate coronary
blood flow and reserve in these patients.
BACKGROUND Permanent ventricular pacing is associated with exercise perfusion defects on myocardial
scintigraphy in the absence of coronary artery disease (CAD). On the basis of studies in
patients with left bundle brunch block, coronary vasodilation with dipyridamole has been
proposed as an alternative to exercise testing for detecting CAD in paced patients, but this
approach has never been tested.
METHODS Fourteen patients with a PVP and normal coronary arteries underwent stress thallium-201
scintigraphy and cardiac catheterization. In these patients and in eight control subjects,
coronary flow velocities were measured in the left anterior descending coronary artery (LAD)
and in the dominant coronary artery before and after adenosine administration.
RESULTS In the paced patients, coronary flow velocities in the LAD and in the dominant coronary
artery were significantly lower than those in the control subjects. In addition, seven patients
showed perfusion defects on dipyridamole thallium-201 single-photon emission computed
tomography, with a specificity of 50% for this test. The defect-related artery in these patients
had lower coronary flow reserve (2.6 6 0.5) as compared with those without perfusion defects
(3.9 6 1.0, p , 0.05) or the control group (3.5 6 0.5, p , 0.05).
CONCLUSIONS Permanent ventricular pacing is associated with alterations in regional myocardial perfusion.
Furthermore, abnormalities of microvascular flow, as indicated by reduced coronary flow
reserve in the defect-related artery, are at least partially responsible for the uncertain
specificity of dipyridamole myocardial perfusion scintigraphy. (J Am Coll Cardiol 2001;37:
124–9) © 2001 by the American College of Cardiology
Approximately one million patients in the U.S. have a
cardiac pacemaker, and as time goes on, the number of
implants is increasing, along with the use of pacing systems
that are more adaptive to normal physiology (1). These
patients are often elderly and may have symptoms, typical or
nontypical, of ischemic heart disease, myocardial infarction
or left ventricular dysfunction, and thus are often referred
for noninvasive evaluation to rule out concomitant coronary
artery disease (CAD).
Exercise myocardial perfusion scintigraphy is a widely
accepted noninvasive technique for detecting ischemic heart
disease; however, as in patients with left bundle branch
block (LBBB) (2,3), ventricular paced rhythm during exer-
cise has been associated with a high incidence of perfusion
defects in the absence of CAD (4,5). In patients with
LBBB, pharmacologic coronary vasodilation with intrave-
nous dipyridamole (6–8) appears to be associated with a
higher specificity than that found with exercise.
On the basis of the aforementioned studies, and given the
electrocardiographic resemblance between LBBB and the
ventricular depolarization that results from right ventricular
apex pacing, the same approach has been proposed for the
latter group of patients but has never been tested.
Despite the electrocardiographic similarities, there are
significant differences in left ventricular endocardial activa-
tion and function between the two situations (9–12). In
addition, the perfusion defects are found in different re-
gions, with the majority of them involving the septum in
LBBB (2,3,13) and the inferior and apical wall (4,5) in
patients with permanent ventricular pacing (PVP).
The different location of the perfusion defects and the
lack of data from paced patients raise questions about the
underlying mechanism and the validity of the proposed
method of assessment.
The purposes of this study were to test the specificity of
dipyridamole myocardial perfusion scintigraphy and to fur-
ther elucidate the effect of PVP on coronary blood flow and
reserve.
METHODS
Patients. The study included 19 patients with permanent,
dual-chamber, rate-adaptive pacemakers inserted for com-
plete atrioventricular block who consented to undergo stress
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thallium-201 scintigraphy and cardiac catheterization
within two months. The patients were recruited into the
study from the pacemaker outpatient clinic. All patients had
to be in sinus rhythm, with right ventricular capture and
$95% ventricular paced beats during the preceding week, as
shown by a review of the pacemaker’s internal monitor. The
following patient groups were excluded: patients with a
previous myocardial infarction, significant valvular disease,
hypertension or left ventricular hypertrophy, left ventricular
ejection fraction ,50%, total plasma cholesterol .220
mg/dl or diabetes mellitus. We also excluded obese patients
and women with large breasts.
Control group. Eight patients who had coronary angiog-
raphy for clinical indications and whose coronary arteries
were free of stenotic lesions comprised the control group.
The same exclusion criteria were also applied to this group.
All patients and control subjects gave their written, in-
formed consent to participate in the study. The study
protocol was approved by the hospital’s Ethics Committee.
Stress protocol. All patients underwent a symptom-
limited treadmill exercise test according to the standard
Bruce protocol. For the purposes of the study, the upper rate
of the pacemaker was programmed up to 160 beats/min.
Three millicuries of thallium were injected during peak
stress, and the patient was encouraged to exercise for 1 min
longer. Imaging was performed as soon as possible after the
end of exercise and 4 h later.
Patients with exercise perfusion defects also underwent a
scintigraphic study under pharmacologic stress with dipyr-
idamole, one month later. All had a 4-min intravenous
infusion of 0.56 mg/kg body weight of dipyridamole. Three
minutes after the end of dipyridamole infusion, 3 mCi of
thallium was administered, and imaging was performed
3 min and 4 h later.
Thallium-201 single-photon emission computed tomog-
raphy. Thallium-201 single-photon emission computed
tomographic (SPECT) imaging was performed with a
dual-head SPECT gamma camera (Optima NX, General
Electric, Milwaukee, Wisconsin) by use of a step-and-shoot
approach every 6° over a 180° clockwise circular orbit,
beginning at a 45° right anterior oblique projection and
ending at 45° left posterior. Filtered back-projection was
performed using a Butterworth filter with a cut-off fre-
quency of 0.4 cycles/pixel to reconstruct transverse tomo-
grams of the left ventricle. These images were further
processed to obtain the short-axis and long-axis sections
perpendicular to the cardiac axes.
The tomograms were divided into six segments for
qualitative interpretation. The short-axis slices were divided
into five regions (inferoseptal, anteroseptal, anterior, lateral
and inferior). The apex was interpreted from the vertical
long-axis view at the mid-ventricular level. Perfusion was
scored qualitatively by consensus of two experienced observ-
ers who were unaware of the other patient data: 0 5 severe
perfusion defect; 1 5 moderate perfusion defect; 2 5 mild
or equivocal perfusion defect; and 3 5 normal perfusion.
Defects in the short-axis slices were confirmed in the other
two planes. A reversible defect was defined as a segment
with a higher score on the rest images. The vascular
territories were assigned as follows: anteroseptal and ante-
rior regions and apex to the left anterior descending coro-
nary artery (LAD); lateral region to the left circumflex
coronary artery (LCx); and inferior and inferoseptal regions
to the right coronary artery (RCA) or LCx, whichever was
the dominant artery.
Coronary angiography. All patients underwent selective
coronary angiography. On completion of diagnostic cardiac
catheterization, the video record of the procedure was
reviewed. Only patients whose coronary arteries were an-
giographically normal were enrolled in the study.
Coronary flow velocity measurements. Immediately after
coronary angiography, a 0.014-in. (0.035-cm), 15-MHz
Doppler guide wire (FloWire, Cardiometrics) was advanced
through the catheter to the proximal LAD and to the
proximal portion of the dominant LCx or RCA. Frequency
analysis of the Doppler signals was carried out in real time
by fast Fourier transform, using a velocimeter (FloMap,
Cardiometrics, Inc, Mountain View, California). Once
baseline flow velocity data were obtained, a bolus injection
of intracoronary adenosine, 18 mg for the left coronary
artery and 12 mg for the RCA were given to obtain data
during hyperemia.
In each artery, all measurements were made at a constant
heart rate of 100 beats/min for both patients and controls
subjects to exclude the influence of variant heart rate. This
was accomplished in the patients by programming the basic
rate of the permanent pacemaker, and in the control subjects
by pacing the right atrial appendage at the same rate
through a temporary pacing lead.
Time-averaged peak coronary flow velocity (APV) was
measured for each vessel. Coronary flow reserve was deter-
mined as the ratio of APV at maximal hyperemia to APV at
baseline. Pretreatment and measurements were done as
previously described (13).
Statistical analysis. Data are expressed as the mean
value 6 SD. Two-way repeated measures analysis of vari-
ance was used to assess drug (adenosine-induced maximal
hyperemia), group and interaction effects. One-way analysis
of variance was used for all other comparisons between the
three groups. Specificity comparisons between dipyridamole
and exercise scintigraphy were performed with McNemar’s
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chi-square test. A p value ,0.05 was considered as statis-
tically significant.
RESULTS
Of the 19 patients initially included in the study, five had
CAD. These patients were excluded from the final analysis.
The mean age of the remaining 14 patients (10 men and 4
women) was 65 6 7 years. Three of them had typical angina
and eight had nontypical chest pain syndrome. In the
control group (6 men), the mean age was 62 6 10 years
(p 5 NS).
Exercise thallium-201 SPECT. All patients were paced
continuously throughout the study. The heart rate achieved
during exercise was 138 6 10 beats/min. Nine patients
showed perfusion defects on exercise myocardial scintigra-
phy, with a specificity of 36%. The distribution of perfusion
defects is shown in Table 1. Perfusion defects were located
more commonly in the inferior (78% [n 5 7]), inferoseptal
(67% [n 5 6]) and apical (55% [n 5 5]) wall. Of the 19
segments with a perfusion defect, three (16%) had a fixed
defect, and the remainder of them were completely or
partially reversible.
Dipyridamole thallium-201 SPECT. The nine patients
with exercise perfusion defects underwent a scintigraphic
study under pharmacologic stress with dipyridamole. We
assumed that the other five would be negative. All patients
were paced continuously throughout the study. The maxi-
mal heart rate during the pharmacologic stress was 83 6 11
beats/min, significantly lower than that achieved during
exercise stress (138 6 10 beats/min, p , 0.05).
Seven patients showed perfusion defects on dipyridamole
myocardial scintigraphy (group I), and seven showed normal
perfusion (group II), with a specificity of 50%. This speci-
ficity was not statistically significantly different from that
found with exercise testing. The distribution of perfusion
defects is shown in Table 1. Perfusion defects were located
in the inferior (100% [n 5 7]) and apical (57% [n 5 4]) wall
(Table 1).
Of the 11 segments with a perfusion defect, two (18%)
had a fixed defect, and the remainder of them were
completely or partially reversible. There were no significant
differences in age between the three groups (group I: 66 6
6 years; group II: 63 6 7 years; control group: 62 6 10
years).
Coronary flow velocity measurements. LEFT CORONARY
ARTERY. In paced patients, APV was 18.7 6 5.5 cm/s at
baseline and 51 6 12.9 cm/s at maximal hyperemia. In the
control subjects, the corresponding values were 25.1 6 5.2
and 71.7 6 16.1 cm/s. There was a significant group effect
(p 5 0.004), both at baseline and during maximal hyper-
Table 1. Patient Data, Scintigraphic Findings and Coronary Flow Reserve at 100 Beats/Min in
Patients With Permanent Ventricular Pacing
Pt. No.
Age
(years)/Gender Exercise Tl-201 SPECT
Dipyridamole
T1-201 SPECT DCA CFR
1 73/M R-inferior, apical, inferoseptal R-inferior, apical 1.8
2 71/M R-inferior, apical R-inferior, apical 2.5
3 64/F R-inferior, Fx-inferoseptal Fx-inferior 2.2
4 70/M Fx-inferior, inferoseptal Fx-inferior 3.3
5 68/M R-inferior, inferoseptal R-inferior 3.2
6 61/F R-inferior, apical, inferoseptal R-inferior, apical 2.5
7 57/M R-inferior, apical, inferoseptal R-inferior, apical 2.7
8 55/F Rr-anterior Negative 4.9
9 67/M R-apical Negative 4.0
10 64/M Negative — 2.5
11 51/F Negative — 4.9
12 67/M Negative — 4.0
13 65/M Negative — 2.7
14 71/M Negative — 4.4
CFR 5 coronary flow reserve; DCA 5 dominant coronary artery; F 5 female; Fx 5 fixed; R 5 reversible; Rr 5 reverse
redistribution; SPECT 5 single-photon emission computed tomography; Tl-201 5 thallium-201.
Table 2. Left Anterior Descending and Dominant Coronary Artery Doppler Flow Velocity
Measurements in Patients With Permanent Ventricular Pacing, With (Group I) and Without
(Group II) Dipyridamole Scintigraphic Perfusion Defects, and in Control Subjects
r-APV (cm/s) h-APV (cm/s)
Group I Group II
Control
Group Group I Group II
Control
Group
LAD*† 21.5 6 4.8 15.9 6 4.8 25.1 6 5.2 55.2 6 12.4 46.8 6 13.0 71.7 6 16.1
DCA*† 20.3 6 7.8 13.2 6 4.0 24.8 6 2.9 50.5 6 16.4 50.5 6 15.8 84.8 6 10.4
*Significant drug effect. †Significant group effect at both baseline and hyperemia.
DCA 5 dominant coronary artery; h-APV 5 time-averaged peak coronary flow velocity at maximal hyperemia; LAD 5 left
anterior descending coronary artery; r-APV 5 time-averaged peak coronary flow velocity at baseline.
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emia. There was also a significant drug effect (p , 0.001)
and interaction (p 5 0.026).
Doppler flow velocity measurements for the three groups
are given in Table 2. There was a significant group effect
(p 5 0.006), both at baseline and during maximal hyper-
emia. The APV was significantly lower in group II than in
the control group, both at baseline and during maximal
hyperemia. There was also a significant drug effect (p ,
0.001) and interaction verging on significance (p 5 0.051).
Coronary flow reserve was 2.7 6 0.8 in group I; 3.0 6 0.3
in group II; and 2.9 6 0.4 in the control group. The differences
between these values were not statistically significant.
DOMINANT CORONARY ARTERY. Two patients from group
I, one patient from group II and one from the control group
had left-dominant coronary arteries.
In paced patients, APV was 16.7 6 7.0 cm/s at baseline
and 50.5 6 15.5 cm/s at maximal hyperemia. The corre-
sponding control values were 24.8 6 2.4 cm/s and 84.8 6
10.4 cm/s. There was a significant group effect (p , 0.001),
both at baseline and during maximal hyperemia. There was
also a significant drug effect (p , 0.001) and interaction
(p , 0.001).
Doppler flow velocity measurements in the three groups
are given in Table 2. There was a significant group effect
(p , 0.001), both at baseline and during maximal hyper-
emia. At baseline, APV in group II was significantly lower
than that in group I or in the control group. At maximal
hyperemia, APV in both groups I and II was significantly
lower than that in the control group (Fig. 1). There was also
a significant drug effect (p , 0.001) and interaction (p ,
0.001).
Coronary flow reserve in group I was 2.6 6 0.5, signifi-
cantly lower than that in group II (3.9 6 1.0, p , 0.05) or
in the control group (3.5 6 0.5, p , 0.05). There was no
statistically significant difference in coronary flow reserve
between group II and the control group (Fig. 2).
DISCUSSION
To our knowledge, this study is the first to assess the
specificity of dipyridamole myocardial perfusion scintigra-
phy and to evaluate coronary blood flow and reserve in
patients with PVP. Our main findings were: 1) exercise and
dipyridamole myocardial perfusion scintigraphy have a sim-
ilar specificity in the detection of CAD; 2) there are
alterations in regional myocardial blood flow associated with
PVP; and 3) impairment of microvascular flow in the
defect-related artery appears to be the underlying mecha-
nism for the intermediate specificity of scintigraphic studies.
Coronary blood flow. This is the first study of coronary
blood flow in patients with long-term ventricular pacing
(32 6 16 months). In these patients, we observed a
significant reduction of coronary flow velocity at baseline
and during maximal hyperemia in both measured coronary
arteries, as compared with that in control subjects. Although
coronary blood flow velocities do not actually represent
volumetric flow, given the similarities between our patients
and control subjects in terms of age, systolic (118 6 13 vs.
122 6 16 mm Hg) and diastolic (69 6 8 vs. 67 6
9 mm Hg) blood pressure, pretreatment regimens and heart
rate (both paced at 100 beats/min), it seems reasonable to
assume that flow velocities provide a valid means of com-
paring blood flow between the two groups. Thus, the
differences we observed can most likely be explained in
terms of a different regulation of coronary artery blood flow
due to local alterations in mechanical work (11,14) arising
from long-term functional and/or structural abnormalities
induced by PVP (15–19).
Figure 1. Mean values with 95% confidence intervals (CIs) of time-
averaged peak coronary flow velocity at baseline (r-APV; open squares)
and maximal hyperemia (h-APV; solid squares) in the dominant coronary
artery in groups I and II (with and without perfusion defects, respectively)
and in the control group.
Figure 2. Mean values with 95% confidence intervals (CIs) of coronary
flow reserve (CFR) in the dominant coronary artery in groups I and II
(with and without perfusion defects, respectively) and in the control group.
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Coronary flow reserve. Coronary flow reserve differences
were found only in the dominant coronary artery in patients
with scintigraphic perfusion defects (group I). This implies
that in these patients, there is impairment of coronary
microvascular flow in the inferior wall, because that wall was
involved in all of the patients with perfusion defects. This
was caused not only to lower coronary blood flow velocities
as compared with control subjects during maximal hyper-
emia, as already discussed, but also to the higher values as
compared with group II at baseline. The latter may be
explained by differences in the degree of associated struc-
tural and functional abnormalities with PVP, because a
similar difference was observed in the corresponding flow
velocities in the LAD.
The absence of differences in coronary flow reserve in the
LAD between the three groups may explained by the low
number of patients with apical perfusion defects (n 5 4) and
the lower contribution of the apex to total LAD flow.
Stress thallium-201 SPECT. Perfusion defects on exer-
cise myocardial scintigraphy, mainly in the inferior, apical
and inferoseptal wall, have been observed in 65% to 75% of
patients free of CAD who were paced through the right
ventricular apex during exercise (4,5). Several hypotheses
have been suggested to explain this. First is coronary
autoregulation, according to regional alterations of mechan-
ical work; second, small-vessel disease as the result of
associated fibrodegenerative changes; third, compression of
the septal arteries during tachycardia; and finally, diaphrag-
matic photon attenuation based on the location of the
findings (20,21).
In our study, during the exercise protocol, the heart rate
was 138 6 10 beats/min, and perfusion defects were
observed in the same vascular territories and with a similar
incidence as found in previous studies (4,5). During the
dipyridamole protocol, the heart rate was 83 6 11 beats/
min, and perfusion defects were observed in the same
regions, although inferoseptal regions were preserved
(Fig. 3).
Ono et al. (21) found that, in dogs, right ventricular
pacing itself may reduce regional myocardial blood flow in
the septum at a pacing rate of 196 6 16 beats/min by
compression of the septal arteries, although LAD flow did
not significantly change.
Combining these findings, the most probable explanation
is that reduced septal flow is a rate-dependent phenomenon
and that the septal hypoperfusion found by Ono et al. (21)
was due to compression of septal branches arising from the
posterior descending coronary artery, rather than from the
LAD.
We found that the remainder of the defects observed,
both during exercise and on dipyridamole scintigraphy, were
associated with reduced coronary flow reserve in the defect-
related artery, indicating abnormalities in microvascular
flow in the same vascular territory. These probably represent
true rather than false positive perfusion defects. Thus, the
low specificity of both exercise and dipyridamole myocardial
perfusion scintigraphy in patients with PVP may explained
by associated abnormalities of microvascular flow.
Previous studies. There is one experimental animal study
(14) and one human study (22) showing that asynchronous
ventricular activation with ventricular pacing at heart rates
slightly above the intrinsic rate is associated with reduced
coronary blood flow in the early-activated region. Also,
reduced regional myocardial work (11,14), oxygen uptake
(11) and free fatty acid metabolism (23) have been observed
in the early-activated region under ventricular pacing. This
is consistent with our findings of reduced coronary flow
velocity at baseline in paced patients as compared with
control subjects, because the LAD supplies the apex and the
dominant coronary artery supplies the inferior wall: these
are probably the earliest activated sites under right ventric-
ular apical pacing (11).
Although Amitzur et al. (22) showed that this effect
disappears after intracoronary adenosine administration—a
finding that conflicts with the persistence of the effect in our
study group—they performed their measurements in the
early phase of ventricular pacing. Thus, they could only
detect early functional changes resulting from pacing in an
apparently healthy substrate and did not take into account
the functional and histologic changes that long-term ven-
tricular pacing produces (15–19).
Two previous studies (24,25) of the effect of right
ventricular apex pacing on coronary flow reserve did not find
any differences in the LAD, as in our study group, but
neither study included the RCA in the results, nor were the
effects of long-term pacing investigated.
Figure 3. Exercise and dipyridamole thallium-201 SPECT stress and rest
images from the fifth patient in Table 1, showing a reversible inferior and
inferoseptal defect during exercise and a reversible inferior defect with
preservation of the inferoseptal region during dipyridamole administration.
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Study limitations. A coronary flow reserve of 2.6 is nor-
mally not considered to be associated with the presence of
myocardial perfusion defects (26). However, because our
measurements were made in the proximal part of the main
coronary arteries, in the case of localized defects, contribu-
tions from other unaffected regions might be expected to
inflate the values measured.
The small number of patients in this study is another
limitation. This was due to the strict screening criteria we
used to exclude other factors that might influence coronary
microvascular flow. Despite this, or perhaps because of this,
we were able to obtain statistically significant results.
Clinical implications. Although our findings should be
confirmed in a larger patient group, it seems that dipyrid-
amole scintigraphy in patients with PVP has nothing to add
in ruling out CAD, as compared with exercise scintigraphy,
and that given the specificity of 50% we found in these
patients, the best approach to exclude concomitant CAD in
such cases is coronary angiography.
Also, because PVP from the right ventricular apex is
associated with alterations in regional myocardial perfusion
and impairment of microvascular flow that may exacerbate
the effects of concomitant CAD, there is one more reason to
investigate alternative and more physiologic sites of pacing.
Conclusions. The findings of this study show that perma-
nent pacing from the right ventricular apex is associated
with alterations in regional myocardial perfusion, and that
impairment of microvascular flow is the underlying mech-
anism for the perfusion defects during either exercise and
dipyridamole myocardial scintigraphy. The low specificity of
the latter method suggests that it is of limited usefulness in
ruling out CAD in paced patients.
Reprint requests and correspondence: Prof. Panos E. Vardas,
Department of Cardiology, Heraklion University Hospital, P.O.
Box 1352 Stavrakia, GR 711 10 Heraklion, Crete, Greece. E-mail:
cardio@med.uoc.gr.
REFERENCES
1. Bernstein AD, Parsonnet V. Survey of cardiac pacing and defibrillation
in the United States in 1993. Am J Cardiol 1996;78:187–96.
2. De Puey EG, Guertler-Krawezynska E, Rolbins WL. Thallium-201
SPECT in coronary artery disease patients with left bundle branch
block. J Nucl Med 1988;29:1479–85.
3. Braat SH, Brugada P, Bar FW, Gorgels AP, Wellens HJ. Thallium-
201 exercise scintigraphy and left bundle branch block. Am J Cardiol
1985;55:224–6.
4. Lakkis NM, He ZX, Verani MS. Diagnosis of coronary artery disease
by exercise thallium-201 tomography in patients with a right ventric-
ular pacemaker. J Am Coll Cardiol 1997;29:1221–5.
5. Tse HF, Lau CP. Long-term effect of right ventricular pacing on
myocardial perfusion and function. J Am Coll Cardiol 1997;29:744–9.
6. Jukema JW, Van der Wall EE, Van der Vis-Melsen MJ, Kruyswijk
HH, Bruschke AV. Dipyridamole thallium-201 scintigraphy for im-
proved detection of stenosis in patients with left bundle branch block.
Eur Heart J 1993;14:53–6.
7. Burns RJ, Galligan L, Wright LM, Lawand S, Burke RJ,
Gladstone PJ. Improved specificity of myocardial thallium-201 single-
photon emission computed tomography in patients with left bundle
branch block by dipyridamole. Am J Cardiol 1991;68:504–8.
8. Lebtahi NE, Stauffer JC, Delaloye A. Left bundle branch block and
coronary artery disease: accuracy of dipyridamole thallium-201 single-
photon emission computed tomography in patients with exercise
anteroseptal perfusion defects. J Nucl Cardiol 1997;4:266–73.
9. Xiao HB, Brecker SJ, Gibson DG. Differing effects of right ventricular
pacing and left bundle branch block on left ventricular function. Br
Heart J 1993;69:166–73.
10. Vassallo JA, Cassidy DM, Marchlinski FE, et al. Endocardial activa-
tion of left bundle branch block. Circulation 1984;69:914–23.
11. Prinzen FW, Hunter WC, Wyman BT, McVeigh ER. Mapping of
regional myocardial strain and work during ventricular pacing: exper-
imental study using magnetic resonance imaging tagging. J Am Coll
Cardiol 1999;33:1735–42.
12. Vassallo JA, Cassidy DM, Miller JM, Buxton AE, Marchlinski FE,
Josephson ME. Left ventricular endocardial activation during right
ventricular pacing: effect of underlying heart disease. J Am Coll
Cardiol 1986;7:1228–33.
13. Skalidis EI, Kochiadakis GE, Koukouraki SI, Parthenakis FI,
Karkavitsas NS, Vardas PE. Phasic coronary flow pattern and flow
reserve in patients with left bundle branch block and normal coronary
arteries. J Am Coll Cardiol 1999;33:1338–46.
14. Delhaas T, Arts T, Prinzen FW, et al. Regional fibre stress–fibre strain
area as an estimate of regional blood flow and oxygen demand in the
canine heart. J Physiol (Lond) 1994;477:481–96.
15. Adomian GE, Beazell J. Myofibrillar disarray produced in normal
hearts by chronic electrical pacing. Am Heart J 1986;112:79–83.
16. Karpawich PP, Justice CD, Cavitt DL, Chang CH. Developmental
sequelae of fixed-rate ventricular pacing in the immature canine heart:
an electrophysiologic, hemodynamic and histopathologic evaluation.
Am Heart J 1990;119:1077–83.
17. Lee MA, Dae MW, Langberg JJ, et al. Effects of long-term right
apical pacing on left ventricular perfusion, innervetion, function and
histology. J Am Coll Cardiol 1994;24:225–32.
18. Prinzen FW, Cheriex EC, Delhaas T, et al. Asymmetric thickness of
the left ventricular wall resulting from asynchronous electric activation:
a study in dogs with ventricular pacing and in patients with left bundle
branch block. Am Heart J 1995;130:1045–53.
19. Van Oosterhout MF, Prinzen FW, Arts T, et al. Asynchronous
electrical activation induces asymmetrical hypertrophy of the left
ventricular wall. Circulation 1998;98:588–95.
20. Olsson RA, Bunger R. Metabolic control of coronary blood flow. Prog
Cardiovasc Dis 1987;29:369–87.
21. Ono S, Nohara R, Kambara H, Okuda K, Kawai C. Regional
myocardial perfusion and glucose metabolism in experimental left
bundle branch block. Circulation 1992;85:1125–31.
22. Amitzur G, Manor D, Pressman A, et al. Modulation of the arterial
coronary blood flow by asynchronous activation with ventricular
pacing. Pacing Clin Electrophysiol 1995;18:697–710.
23. Yoshida H, Shirotami M, Mochizuki M, Sakata K. Assessment of
myocardial fatty acid metabolism in atrioventricular synchronous
pacing: analysis of iodine-123–labeled beta-methyl iodophenyl penta-
decanoic acid SPECT. J Nucl Cardiol 1999;6:33–40.
24. Kolettis TM, Kremastinos DT, Kyriakides ZS, Tsirakos A, Toutouzas
PK. Effects of atrial, ventricular and atrioventricular sequential pacing
on coronary flow reserve. Pacing Clin Electrophysiol 1995;18:1628–
35.
25. Takeuchi M, Nohtomi Y, Kuroiwa A. Effect of ventricular pacing on
coronary blood flow in patients with normal coronary arteries. Pacing
Clin Electrophysiol 1997;20:2463–9.
26. Joye JD, Schulman DS, Lasorda D, Farah T, Donohue BC, Reichek
N. Intracoronary Doppler guide wire versus stress single-photon
emission computed tomographic thallium-201 imaging in assessment
of intermediate coronary stenoses. J Am Coll Cardiol 1994;24:940–7.
129JACC Vol. 37, No. 1, 2001 Skalidis et al.
January 2001:124–9 Myocardial Perfusion in Paced Patients
